Meanwhile, Corinne Treger, the chief executive of French pharmaceutical company Biosantech, said a phase two trial of a therapeutic vaccine to treat HIV, not prevent it, was showing some positive results.

If the experimental vaccine, known as « Tat Oyi », is proved to be safe and effective, she said people with HIV could receive several injections to control their virus permanently instead of taking antiretroviral treatment, which can have side effects and cost thousands of dollars a year.

Lire la suite

Suivez-nous et partagez :
Catégories : ActuPresse